Artículos de revistas sobre el tema "In Utero Drug Exposures"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "In Utero Drug Exposures".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Huestis, Marilyn A. y Robin E. Choo. "Drug abuse’s smallest victims: in utero drug exposure". Forensic Science International 128, n.º 1-2 (agosto de 2002): 20–30. http://dx.doi.org/10.1016/s0379-0738(02)00160-3.
Texto completoBech, Laura Fuglsang, Christoffer Polcwiartek, Kristian Kragholm, Mikkel Porsborg Andersen, Christopher Rohde, Christian Torp-Pedersen, Jimmi Nielsen y Søren Hagstrøm. "In utero exposure to antiepileptic drugs is associated with learning disabilities among offspring". Journal of Neurology, Neurosurgery & Psychiatry 89, n.º 12 (3 de agosto de 2018): 1324–31. http://dx.doi.org/10.1136/jnnp-2018-318386.
Texto completoWright, Tricia. "Biochemical Screening for in utero Drug Exposure". Drug Metabolism Letters 9, n.º 2 (27 de octubre de 2015): 65–71. http://dx.doi.org/10.2174/1872312809666150904182334.
Texto completoMulvihill, A. O., P. D. Cackett, N. D. George y B. W. Fleck. "Nystagmus secondary to drug exposure in utero". British Journal of Ophthalmology 91, n.º 5 (13 de diciembre de 2006): 613–15. http://dx.doi.org/10.1136/bjo.2006.105569.
Texto completoCackett, Peter D., Nick George, Brian Fleck y Alan Mulvihill. "Nystagmus Secondary to Drug Exposure In Utero". Journal of American Association for Pediatric Ophthalmology and Strabismus 10, n.º 1 (febrero de 2006): 84. http://dx.doi.org/10.1016/j.jaapos.2006.01.138.
Texto completoMeador, Kimford J. "Effects of in Utero Antiepileptic Drug Exposure". Epilepsy Currents 8, n.º 6 (6 de octubre de 2008): 143–47. http://dx.doi.org/10.1111/j.1535-7511.2008.00273.x.
Texto completoSchraw, Jeremy M. "Anticancer drug exposure in utero and leukemia". Blood 143, n.º 4 (25 de enero de 2024): 293–94. http://dx.doi.org/10.1182/blood.2023022496.
Texto completo&NA;. "Long-Term Effects of In Utero Drug Exposure". AJN, American Journal of Nursing 108, n.º 5 (mayo de 2008): 21. http://dx.doi.org/10.1097/01.naj.0000317982.71371.39.
Texto completoGray, Teresa y Marilyn Huestis. "Bioanalytical procedures for monitoring in utero drug exposure". Analytical and Bioanalytical Chemistry 388, n.º 7 (17 de marzo de 2007): 1455–65. http://dx.doi.org/10.1007/s00216-007-1228-9.
Texto completoMeador, Kimford. "Anatomical and Behavioral Effects of in Utero Exposure to Antiepileptic Drugs". Epilepsy Currents 5, n.º 6 (noviembre de 2005): 212–16. http://dx.doi.org/10.1111/j.1535-7511.2005.00067.x.
Texto completoCosden, Merith, Stacey Peerson y Katherine Elliott. "Effects of Prenatal Drug Exposure on Birth Outcomes and Early Child Development". Journal of Drug Issues 27, n.º 3 (julio de 1997): 525–39. http://dx.doi.org/10.1177/002204269702700306.
Texto completoJackson, Adam, Heather Ward, Rebecca Louise Bromley, Charulata Deshpande, Pradeep Vasudevan, Ingrid Scurr, John Dean et al. "Exome sequencing in patients with antiepileptic drug exposure and complex phenotypes". Archives of Disease in Childhood 105, n.º 4 (3 de septiembre de 2019): 384–89. http://dx.doi.org/10.1136/archdischild-2018-316547.
Texto completoTakcı, Sahin, Cihangül Bayhan, Tolga Celik y Sule Yiğit. "Hypotonia and poor feeding in an infant exposed to lamotrigine and valproic acid in utero". Turkish Journal of Pediatrics 55, n.º 5 (25 de octubre de 2013): 546–48. http://dx.doi.org/10.24953/turkjped.2013.1551.
Texto completo&NA;. "New guidelines concerning in utero drug exposure during pregnancy". Reactions Weekly &NA;, n.º 298 (abril de 1990): 1. http://dx.doi.org/10.2165/00128415-199002980-00001.
Texto completoEhrenkranz, R. A. "In utero antiepileptic drug exposure: Fetal death and malformations". Yearbook of Neonatal and Perinatal Medicine 2007 (enero de 2007): 47–49. http://dx.doi.org/10.1016/s8756-5005(08)70032-5.
Texto completoMeador, K. J., G. A. Baker, R. H. Finnell, L. A. Kalayjian, J. D. Liporace, D. W. Loring, G. Mawer, P. B. Pennell, J. C. Smith y M. C. Wolff. "In utero antiepileptic drug exposure: Fetal death and malformations". Neurology 67, n.º 3 (7 de agosto de 2006): 407–12. http://dx.doi.org/10.1212/01.wnl.0000227919.81208.b2.
Texto completoBrooks-Gunn, Jeanne. "Effects of In Utero Drug Exposure on Children's Development". Archives of Pediatrics & Adolescent Medicine 148, n.º 1 (1 de enero de 1994): 33. http://dx.doi.org/10.1001/archpedi.1994.02170010035007.
Texto completoHattan, David G. "In Utero Phase Carcinogenicity Testing". International Journal of Toxicology 17, n.º 3 (abril de 1998): 337–53. http://dx.doi.org/10.1080/109158198226611.
Texto completoBada, H. S. "Central and autonomic system signs with in utero drug exposure". Archives of Disease in Childhood - Fetal and Neonatal Edition 87, n.º 2 (1 de septiembre de 2002): 106F—112. http://dx.doi.org/10.1136/fn.87.2.f106.
Texto completoSibiude, Jeanne, Josiane Warszawski y Stéphane Blanche. "Tolerance of the newborn to antiretroviral drug exposure in utero". Expert Opinion on Drug Safety 14, n.º 5 (1 de marzo de 2015): 643–54. http://dx.doi.org/10.1517/14740338.2015.1019462.
Texto completode Castro, Ana, Hendreé E. Jones, Rolley E. Johnson, Teresa R. Gray, Diaa M. Shakleya y Marilyn A. Huestis. "Maternal Methadone Dose, Placental Methadone Concentrations, and Neonatal Outcomes". Clinical Chemistry 57, n.º 3 (1 de marzo de 2011): 449–58. http://dx.doi.org/10.1373/clinchem.2010.154864.
Texto completoVajda, F. J. E., T. J. O'Brien, J. Graham, A. A. Hitchcock, C. M. Lander y M. J. Eadie. "Anti-epileptic drug exposure and risk of foetal death in utero". Acta Neurologica Scandinavica 137, n.º 1 (31 de agosto de 2017): 20–23. http://dx.doi.org/10.1111/ane.12816.
Texto completoHite, Cecelia y Michael Shannon. "Clinical Profile of Apparently Healthy Neonates With In Utero Drug Exposure". Journal of Obstetric, Gynecologic & Neonatal Nursing 21, n.º 4 (julio de 1992): 305–9. http://dx.doi.org/10.1111/j.1552-6909.1992.tb01741.x.
Texto completoKutlay, Baran, Sim Bayramoglu, A. Irfan Kutlar y Narter Yesildaglar. "An acardiac acephalic monster following in-utero anti-epileptic drug exposure". European Journal of Obstetrics & Gynecology and Reproductive Biology 65, n.º 2 (abril de 1996): 245–48. http://dx.doi.org/10.1016/0301-2115(95)02337-2.
Texto completoLittlejohns, Carl S., David J. Clarke y John A. Corbett. "Tourette-Like Disorder in Asperger's Syndrome". British Journal of Psychiatry 156, n.º 3 (marzo de 1990): 430–33. http://dx.doi.org/10.1192/bjp.156.3.430.
Texto completoNapiorkowski, Beata, Barry M. Lester, M. Catherin Freier, Susan Brunner, Laura Dietz, Andrea Nadra y William Oh. "Effects of In Utero Substance Exposure on Infant Neurobehavior". Pediatrics 98, n.º 1 (1 de julio de 1996): 71–75. http://dx.doi.org/10.1542/peds.98.1.71.
Texto completoGinsberg, Gary, Dale Hattis, Richard Miller y Babasaheb Sonawane. "Pediatric Pharmacokinetic Data: Implications for Environmental Risk Assessment for Children". Pediatrics 113, Supplement_3 (1 de abril de 2004): 973–83. http://dx.doi.org/10.1542/peds.113.s3.973.
Texto completoConcheiro, Marta, Eva González-Colmenero, Elena Lendoiro, Ana Concheiro-Guisán, Ana de Castro, Angelines Cruz-Landeira y Manuel López-Rivadulla. "Alternative Matrices for Cocaine, Heroin, and Methadone In Utero Drug Exposure Detection". Therapeutic Drug Monitoring 35, n.º 4 (agosto de 2013): 502–9. http://dx.doi.org/10.1097/ftd.0b013e31828a6148.
Texto completoHodel, E. M., C. Marzolini, C. Waitt y N. Rakhmanina. "Pharmacokinetics, Placental and Breast Milk Transfer of Antiretroviral Drugs in Pregnant and Lactating Women Living with HIV". Current Pharmaceutical Design 25, n.º 5 (3 de junio de 2019): 556–76. http://dx.doi.org/10.2174/1381612825666190320162507.
Texto completoVajda, F. J. E., T. J. O'Brien, J. Graham, C. M. Lander y M. J. Eadie. "Associations between particular types of fetal malformation and antiepileptic drug exposurein utero". Acta Neurologica Scandinavica 128, n.º 4 (6 de marzo de 2013): 228–34. http://dx.doi.org/10.1111/ane.12115.
Texto completoBowman, Pamela y Bijay Vaidya. "Suspected Spontaneous Reports of Birth Defects in the UK Associated with the Use of Carbimazole and Propylthiouracil in Pregnancy". Journal of Thyroid Research 2011 (2011): 1–5. http://dx.doi.org/10.4061/2011/235130.
Texto completoMorrison, Janna L., K. Wayne Riggs y Dan W. Rurak. "Fluoxetine during pregnancy: impact on fetal development". Reproduction, Fertility and Development 17, n.º 6 (2005): 641. http://dx.doi.org/10.1071/rd05030.
Texto completoDegiacomo, Jessica y Sherry Luedtke. "Neonatal Toxicity From Escitalopram Use In Utero: A Case Report". Journal of Pediatric Pharmacology and Therapeutics 21, n.º 6 (1 de diciembre de 2016): 522–26. http://dx.doi.org/10.5863/1551-6776-21.6.522.
Texto completoO'Donnell, Karen J., Geoffrey M. Georgi, Jeannine L. Gingras, Luanne McAdams, Richard Granowsky y Allen P. Killam. "PRENATAL INTERVENTION FOR CHILDREN WITH IN UTERO EXPOSURE TO MATERNAL DRUG USE. 643". Pediatric Research 39 (abril de 1996): 110. http://dx.doi.org/10.1203/00006450-199604001-00665.
Texto completoSmith, Andrew L., Jeffrey A. Cohen, Daniel Ontaneda y Mary Rensel. "Pregnancy and multiple sclerosis: Risk of unplanned pregnancy and drug exposure in utero". Multiple Sclerosis Journal - Experimental, Translational and Clinical 5, n.º 4 (octubre de 2019): 205521731989174. http://dx.doi.org/10.1177/2055217319891744.
Texto completoKintz, P. "Contribution of in utero drug exposure when interpreting hair results in young children". Forensic Science International 249 (abril de 2015): 314–17. http://dx.doi.org/10.1016/j.forsciint.2014.09.014.
Texto completoSalmen, Teodor, Vlad Dima, Claudia Gabriela Potcovaru, Bianca Margareta Mihai, Delia Cinteza y Roxana-Elena Bohiltea. "The neuroprotective effects of magnesium sulfate in utero exposure". Romanian Journal of Pediatrics 71, S2 (30 de noviembre de 2022): 36–39. http://dx.doi.org/10.37897/rjp.2022.s2.8.
Texto completoReinarz, Susan y Jenny Ecord. "Drug-of-Abuse Testing in the Neonate". Neonatal Network 18, n.º 8 (diciembre de 1999): 55–61. http://dx.doi.org/10.1891/0730-0832.18.8.55.
Texto completoBarrau, Mathilde, Xavier Roblin, Leslie Andromaque, Aurore Rozieres, Mathias Faure, Stéphane Paul y Stéphane Nancey. "What Should We Know about Drug Levels and Therapeutic Drug Monitoring during Pregnancy and Breastfeeding in Inflammatory Bowel Disease under Biologic Therapy?" Journal of Clinical Medicine 12, n.º 23 (4 de diciembre de 2023): 7495. http://dx.doi.org/10.3390/jcm12237495.
Texto completoPerl, Anna Sechser, Blaine W. Robinson, Jaclyn A. Biegel, Elaine H. Zackai, Christos P. Kolaris y Carolyn A. Felix. "Congenital Amniotic Band Syndrome and MLL Rearranged Neonatal Leukemia in an Infant with Multiple Pre-Conception and In Utero Exposures." Blood 108, n.º 11 (16 de noviembre de 2006): 4286. http://dx.doi.org/10.1182/blood.v108.11.4286.4286.
Texto completoKing, Terri A., Jeffrey M. Perlman, Abbot R. Laptook, Nancy Rollins, Gregory Jackson y Bertis Little. "Neurologic Manifestations of In Utero Cocaine Exposure in Near-Term and Term Infants". Pediatrics 96, n.º 2 (1 de agosto de 1995): 259–64. http://dx.doi.org/10.1542/peds.96.2.259.
Texto completoMcGlone, Laura, Helen Mactier, Huda Hassan y Gail Cooper. "In utero drug and alcohol exposure in infants born to mothers prescribed maintenance methadone". Archives of Disease in Childhood - Fetal and Neonatal Edition 98, n.º 6 (8 de julio de 2013): F542—F544. http://dx.doi.org/10.1136/archdischild-2013-304158.
Texto completoKintz, P. "O1: Contribution of in-utero drug exposure when interpreting hair results in young children". Toxicologie Analytique et Clinique 26, n.º 2 (junio de 2014): S4—S5. http://dx.doi.org/10.1016/s2352-0078(14)70009-5.
Texto completoYuan, Xia, Hongjun Liu, Yufeng Li, Wen Li, Huiqian Yu y Xia Shen. "Ribbon Synapses and Hearing Impairment in Mice After in utero Sevoflurane Exposure". Drug Design, Development and Therapy Volume 14 (julio de 2020): 2685–93. http://dx.doi.org/10.2147/dddt.s253031.
Texto completoReddy, Doodipala Samba, Jonathan Brewer y Maunica Manchi. "Is Prenatal Valproate Exposure a Risk Factor for Autism". International Journal of Pharmaceutical Sciences and Nanotechnology 11, n.º 2 (31 de marzo de 2018): 4007–11. http://dx.doi.org/10.37285/ijpsn.2018.11.2.1.
Texto completoRuda, Albert. "The DES Daughters in Spain: Liability for Damage Caused by the Exposure to a Defective Drug in Utero". European Review of Private Law 21, Issue 2 (1 de marzo de 2013): 625–42. http://dx.doi.org/10.54648/erpl2013032.
Texto completoJevtovic-Todorovic, Vesna. "Exposure of Developing Brain to General Anesthesia". Anesthesiology 128, n.º 4 (1 de abril de 2018): 832–39. http://dx.doi.org/10.1097/aln.0000000000002047.
Texto completoBoskovic, Rada, Julia Klein, Cindy Woodland, Tanya Karaskov y Gideon Koren. "The role of the placenta in variability of fetal exposure to cocaine and cannabinoids: A twin study". Canadian Journal of Physiology and Pharmacology 79, n.º 11 (1 de noviembre de 2001): 942–45. http://dx.doi.org/10.1139/y01-080.
Texto completoGupta, Manish, Alan O. Mulvihill, Gerassimos Lascaratos, Brian W. Fleck y Nick D. George. "Nystagmus and Reduced Visual Acuity Secondary to Drug Exposure In Utero: Long-Term Follow-up". Journal of Pediatric Ophthalmology & Strabismus 49, n.º 1 (15 de marzo de 2011): 58–63. http://dx.doi.org/10.3928/01913913-20110308-01.
Texto completoAlmgren, Malin, Bengt Källén y Catharina Lavebratt. "Population-based study of antiepileptic drug exposure in utero—Influence on head circumference in newborns". Seizure 18, n.º 10 (diciembre de 2009): 672–75. http://dx.doi.org/10.1016/j.seizure.2009.09.002.
Texto completo